Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioharvest Sciences (BHST) Shares Outstanding (Weighted Average) (2023 - 2025)

Historic Shares Outstanding (Weighted Average) for Bioharvest Sciences (BHST) over the last 3 years, with Q3 2025 value amounting to $17.4 million.

  • Bioharvest Sciences' Shares Outstanding (Weighted Average) rose 47.85% to $17.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.4 million, marking a year-over-year increase of 47.85%. This contributed to the annual value of $16.2 million for FY2024, which is 305533150.94% up from last year.
  • Bioharvest Sciences' Shares Outstanding (Weighted Average) amounted to $17.4 million in Q3 2025, which was up 47.85% from $17.3 million recorded in Q2 2025.
  • Bioharvest Sciences' 5-year Shares Outstanding (Weighted Average) high stood at $17.4 million for Q3 2025, and its period low was $400.0 during Q3 2023.
  • Over the past 3 years, Bioharvest Sciences' median Shares Outstanding (Weighted Average) value was $16.3 million (recorded in 2024), while the average stood at $12.8 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first surged by 433529425.0% in 2024, then surged by 47.85% in 2025.
  • Over the past 3 years, Bioharvest Sciences' Shares Outstanding (Weighted Average) (Quarter) stood at $13.5 million in 2023, then grew by 19.66% to $16.2 million in 2024, then increased by 7.6% to $17.4 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $17.4 million for Q3 2025, versus $17.3 million for Q2 2025 and $17.3 million for Q1 2025.